RESUMO
Abstract Introduction: In Mexico, cardiac rehabilitation (CR) as an interdisciplinary intervention with therapeutic impact in patients with heart disease is growing. There is the need to know actual conditions of CR in our country. Objectives: The objective of this National Registry is to follow-up those existing and new CR units in Mexico through the comparison between the two previous registries, RENAPREC-2009 and RENAPREC II-2015 studies. This is a descriptive study focused on diverse CR activities such as assistance training, and certification of health professionals, barriers, reference, population attended, interdisciplinarity, permanence over time, growth prospects, regulations, post-pandemic condition, integrative characteristics, and scientific research. Results: Data were collected from 45 CR centers in the 32 states, 75.5% are private practice units, 67% are new, 33% were part of RENAPREC II-2015, and 17 have continued since 2009. With a better distribution of CR units along the territory, the median reference of candidates for CR programs is 9% with a significant reduction into tiempo of enrollment to Phase II admission (19 ± 11 days). Regarding to previous registries, the coverance of Phases I, II, and III is 71%, 100%, and 93%, respectively; and a coverance increases in evaluation, risk stratification, and prescription, more comprehensive attendance and prevention strategies. Conclusions: CR in Mexico has grown in the past 7 years. Even there is still low reference and heterogeneity in specific processes, there are strengths such as interdisciplinarity, scientific professionalization of specialists, national diversification, and an official society that are consolidated over time.
resumen está disponible en el texto completo
RESUMO
Con la finalidad de evitar las obstrucciones del circuito extracorpóreo o la sobre-heparinización cuando se utiliza en pacientes el hemodiafilter, se diseñó un sistema de vigilancia de su funcionamiento basado en la colocación de 2 transductores de presión en el hemodiafilter (Diafilter-20S. Amicon), uno colocado en el circuito arterial (A) y otro en el venoso (V), cuantificándose continuamente estas presiones medias y obteniéndose sus diferencias, denominadas presión diferencial (D). Nuestros resultados evidencian que la presión óptima diferencial para el funcionamiento de hemodiafilter es de 45.292mmHg, manteniendose su margen de eficiencia entre 31.46 y 59.11mmHg